Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CEO’ operating in the Health Care space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Othman Laraki
Co-founder & CEO of Color
Othman Laraki, MS, MBA, is the Co-founder and Chief Executive Officer of Color, a health technology company building public health infrastructures such as scaled and efficient testing to contain the COVID-19 pandemic or using genomics for population health. Previously, Othman co-founded Mixer Labs and developed its GeoAPI platform, a powerful location engine for developers. After the company was acquired by Twitter in 2009, he served as the social media network’s Vice President of Product and helped expand its user base from 50 to 200 million unique accounts. Before this, Othman spent several years at Google, where he played an integral role developing front-end products, including the Chrome browser. Othman is a long-time investor and advisor to leading companies such as Pinterest, AngelList, Slack and Instacart, and serves as a board member for ESI Group and Frontier Medicines. He holds degrees in computer science and management from Stanford University and the Massachusetts Institute of Technology.
Follow Othman Laraki:
About Color: Color is a population health technology company that enables the delivery of advanced healthcare through clinical genetics.
Varsha Rao
Chief Executive Officer of Nurx
Varsha Rao is the CEO of Nurx, which is revolutionizing healthcare by home-delivering prescriptions, medication, and screening tests. She is a Board Member at ViaSat Inc., and the former COO of Clover Health, a health insurance startup developing an innovative platform that collects and analyzes long-term medical data to improve the health management and wellbeing of its clients. Varsha previously served as Head of Global Operations at Airbnb, where she was responsible for managing 16 offices across the globe and leading the company’s customer service and trust and safety teams in Oregon, Portland, Singapore, Dublin and San Francisco. Under her leadership, the company’s operations in Asia expanded, with many new hosts and visitors joining the Airbnb family. However, her entrepreneurial journey began much earlier, in 1998 when she founded Eve.com together with Mariam Naficy. Eve.com quickly became the leading e-commerce retailer for beauty and accessories. Within two years the company grew to 125 employees. Eve.com was sold to Idealab in early 2000 for $110M. In 1999, Fortune Magazine named the company as the 6th Best e-commerce site. Between founding Eve.com and landing at Airbnb, Rao has held a variety of senior roles. She was appointed VP, Category Marketing at Keen/Ingenio (acquired by AT&T) in 2001 and managed P&L for new and emerging major categories. In 2004-2008, she was VP, General Manager for OldNavy.com, the online division of Gap, Inc., where she led the company’s product development, marketing and merchandising efforts, resulting in a 60% increase in revenues. Rao went on to join SingTel as CEO, Digital Media in 2008 and led the team to launch its local search & reviews business inSing.com. After 3 years at SingTel she left to become Senior Vice President, International for LivingSocial where she was the first LivingSocial employee in Asia. As Senior VP, Rao managed more than 2,000 employees in the company’s network of offices in Asia, Australia, New Zealand, Latin America and Europe. Varsha is a Sequoia Capital Scout, and a mentor for the KStart Catalyst, an incubator and seed investment program for early stage startups in India. She herself has also invested in several startups in various fields including e-commerce, finance and renewable energy. In 2014, she was named by San Francisco Business Times as one of the ‘Most Influential Business Women’ in the Bay Area and in 2016 she featured in The Boardlist’s top 20 list of women every Silicon Valley tech company should be adding to their board. Rao received her BS/BA in Economics/Math from the University of Pennsylvania. For two years following graduation, she worked at the Wasserstein Perella financial consulting firm, where she advised clients on private and public investment strategies. She then returned to school to obtain an MBA from Harvard Business School. As a strong believer in the power of education she contributes to a variety of educational initiatives for underprivileged children and youth. Among them Breakthrough, a program that works to motivate and empower K12 students to continue to higher education and excel academically and professionally.
Follow Varsha Rao:
About Nurx: Nurx is a digital healthcare company offering 10 services across reproductive health, at-home testing, dermatology, migraine care, and more.
James Park
CEO and Co-Founder of Fitbit
James is our Co-founder and has served as our Chairman since May 2015, as a member of our board of directors since March 2007, and as our President and CEO since September 2007. Previously, James served as a Director of Product Development at CNET Networks, as the President and a Co-founder of Wind-Up Labs, Inc. (an online photo-sharing company acquired by CNET Networks in April 2005). He was also CTO and Co-Founder of Epesi Technologies, Inc., a software company. James attended Harvard College where he studied Computer Science. He was selected to serve as a member of our board of directors due to the perspective and experience he brings as our Co-Founder, President, and CEO.
Follow James Park:
About Fitbit: Fitbit offers compact, wireless, wearable sensors that track a person’s daily activities in order to promote a healthy lifestyle.
Sherri Douville
Chief Executive Officer of Medigram
Sherri Douville is CEO & Board Member at Medigram and is a sought-after speaker and author in mobile medical technology, other healthcare related industries, leadership, risk management, mobile security, and governance. Ms. Douville is honored to strategically build, grow, and lead multi-disciplinary, multi industry teams at Medigram and in the market to solve the leading cause of preventable death –a delay in information. Ms. Douville is co-chair of the technical trust and identity standard subgroup for the healthcare industry for clinical IoT through IEEE and UL and has been published and quoted in both mainstream and industry media such as CIO.com, the San Jose Mercury News, NBC, Becker’s Hospital Review, ThisWeekinHealthIT and HITInfrastructure.com. Other industry leadership has included serving on the board of the NorCal HIMSS and teaching continuing education credit in mobile security for CISSP, the information security certification. She is co-author for a number of technical articles and papers, a forthcoming Springer book chapter on Engineering Trust in Clinical IoT and is the lead author and editor for the #1 hottest new release in medical technology and medical informatics on Amazon, and the #1 BookAuthority ebook in the world for healthcare in 2021, Mobile Medicine: Overcoming People, Culture, and Governance (Taylor & Francis). Ms. Douville led the development of this industry guide to mobile computing in medicine and built the international, multi industry, multi disciplinary team behind it. Prior to her current work in the mobile medicine, privacy, security, health IT and AI industries, Sherri worked in the medical device space consulting in the areas of physician acceptance and economic feasibility for medical devices. Prior to that, she worked for over a decade with products addressing over a dozen disease states at Johnson & Johnson and was recognized for industry thought leadership there by McGraw-Hill and won a number of awards. Ms. Douville has a Bachelor of Combined Science degree from Santa Clara University and has completed certificates in electrical engineering, computer science, AI and ML through MIT. She advises and serves startups, boards, and organizations including as a member of the Board of Fellows for Santa Clara University and an advisor to the Santa Clara University Leavey School of Business Corporate Board Education initiatives, the Black Corporate Board Readiness Program, LatinX Corporate Board Readiness Program and an advisory board member to the Women’s Corporate Board Readiness Program.
Follow Sherri Douville:
About Digital Directors Network, Medigram, Taylor & Francis Group: Medigram provides instant insight to save lives and make hospitals millions on iOS, Android, & the web. It is a full stack system.
Anthony P Mack
Founding Chairman & CEO of Virpax Pharmaceuticals Inc.
Anthony P. Mack has more than 25 years of experience in the pharmaceutical and finance industries. Prior to founding Virpax in 2016, Mr. Mack founded Scilex Pharmaceuticals and served as President and CEO until February 2018. Scilex was sold to a publicly-traded company. Mr. Mack founded his first pharmaceutical company ProSolus Pharmaceuticals in 2009, where he served as President before selling the company to Mission Pharmacal in 2015. Mr. Mack has held high-level management positions with Purdue Pharma, Endo Pharmaceuticals, Novartis, and EKR Therapeutics. He has led training, marketing, and commercial distribution for billion-dollar pain management products and has forged key strategic alliances. Mr. Mack holds an Executive MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University.
Follow Anthony P Mack:
About Virpax Pharmaceuticals Inc.: Our product candidates are being developed to manage global unmet needs in the areas of cancer and non-cancer pain, PTSD, and CNS Disorder.
Lin Jixun
Founder & CEO of ACON Laboratories
Lin Jixun has served as our director since 2008 and is the founder and chief executive officer of ACON Laboratories Inc., a worldwide leading manufacturer of high-quality rapid diagnostic test products. Mr. Lin founded ACON Laboratories Inc. in 1995 and serves on the company’s board of directors. He also serves on the board of directors for ACEA BioSciences Inc., a company providing innovative cell-based assay systems for basic life science research and drug discovery. Mr. Lin received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and a Bachelor of Medicine from Zhejiang Medical University.
Follow Lin Jixun:
About ACON Laboratories: ACON Laboratories is a biotechnology firm that offers medical diagnostic and healthcare products.
Shannon Ralston
President & CEO of Angel Staffing
Shannon Ralston is the Founder, President and CEO of Angel Staffing, Inc. with the responsibility for overseeing all aspects of the business from marketing to government contract obligations. Shannon began her college career at the University of Akron on an Army ROTC scholarship and graduated with her Bachelor’s Degree in Nursing and a minor in Military Science and History at East Central University in Ada, Oklahoma. Prior to starting Angel Staffing, Shannon worked in healthcare as a Registered Nurse specializing in Oncology and Bone Marrow Transplants.
Follow Shannon Ralston:
About Angel Staffing: Angel Staffing is a San Antonio based corporation that serves private, state and federal medical treatment facilities,.
Adam Karp
Co-Founder & CEO of Lively
Prior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.
Follow Adam Karp:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Gwyneth Paltrow
Founder & Chief Executive Officer of Goop
Gwyneth Paltrow is one of today’s most prolific and celebrated actors in both television and film. Additionally, Paltrow continues to develop her lifestle brand: Goop; wellness advice, clean beauty, fashion & home. A testament to her undeniable acting talent is Paltrow’s role in Shakespeare in Love that catapulted her into awards stardom with Best Actress honors at the Golden Globes, Screen Actors Guild Awards, and Academy Awards. In 2011. Gwyneth Paltrow was also honored with an Emmy Award for Guest Actress in a Comedy Series for her role as substitute teacher Holly Holiday on Fox’s smash-hit musical series Glee. In 2013, Paltrow published her second cookbook, It’s All Good, which joined her first-ever cookbook, My Father’s Daughter (published April 2011), on the New York Times Best Sellers list. She first established her credibility in the culinary field when she cowrote Spain, A Culinary Road Trip with acclaimed chef Mario Batali.
Follow Gwyneth Paltrow:
About Goop: Goop is a lifestyle brand providing digital content and commerce.
Laurence Girard
CEO & Founder of Fruit Street
Laurence Girard is the CEO and Founder of Fruit Street which is the first company to deliver the CDCs National Diabetes Prevention Program via telehealth and live video conferencing with registered dietitians. The company had raised more than $20 million in funding from approximately 300 physician investors. Laurence graduated from the Harvard Extension School with a Bachelor’s Degree. His passion for entrepreneurship started during his first year of college when the Harvard Innovation Lab was opened in the Harvard Business School campus. While in college, Laurence was volunteering in an emergency room while taking a nutrition epidemiology course. It was at this point he decided our healthcare system needed to focus more on prevention and that he decided to focus his career in public health, technology, and entrepreneurship. Laurence is also the Managing Director of Hippocrates Ventures, a physician funded VC fund. His company Fruit Street recently launched COVIDMD.com, a new national telemedicine service battling the COVID-19 pandemic.
Follow Laurence Girard:
About Fruit Street, Hippocrates Ventures, New Amsterdam Football Club: Fruit Street is a developer of a digital diabetes prevention and weight loss program.
Harpreet Rai
CEO of ŌURA
Harpreet Singh Rai is the chief executive officer of Oura and a member of its board. He was previously at Eminence Capital, a L/S Equity Hedge Fund where he was a TMT Portfolio Manager. Previously he was at Morgan Stanley in their M&A Group in New York.
Follow Harpreet Rai:
About ŌURA: ŌURA is a wellness ring and app used for sleep improvement and performance.
George Archos
Co-Founder, Chairman and CEO of Verano Holdings
George Archos is the founder & CEO of Verano Holdings. He is a logistics and operations guru. Building on his extensive experience in coordinating complex freight delivery operations, as well as designing and operating highly-successful restaurants, George entered the cannabis industry in 2014 when he founded Ataraxia Grow and Labs in Illinois and was the first to receive authorization to grow medical cannabis out of 21 recipients of the coveted medical licenses. George’s diligence, perseverance, and tireless work ethic have made him one of the cannabis industry’s most successful entrepreneurs. Leveraging his unparalleled devotion to quality and a unique results-oriented approach to the cannabis industry, George has overseen the development of some of cannabis’s most highly-coveted operations and brands. George’s restaurants across the Chicagoland area, including Wildberry Pancakes & Café, Westwood Tavern & Tap and the Scout Waterhouse & Kitchen, all bear the imprint of his relentless devotion to quality and unrivaled customer service, earning him multiple awards and recognition. George’s unique experience, his admirable drive, and his unrelenting commitment to quality, coupled with his capacity to establish, build, and effectively run multi-jurisdictional companies, are an asset to Verano Holdings.
Follow George Archos:
About Verano Holdings: Verano is a vertically integrated, multi-state cannabis operator.
Paul Black
CEO of Allscripts
Paul Black serves as Allscripts Chief Executive Officer. Paul was appointed CEO in December 2012 after having served on Allscripts Board of Directors for eight months. As Chief Executive Officer, Paul leads the direction of the company and its global commitment to delivering an Open, Connected Community of HealthTM.
Follow Paul Black:
About Allscripts: Allscripts provides healthcare information technology solutions.
April Koh
Co-Founder & CEO of Spring Health
April Koh is Co-Founder & CEO at Spring Care. She is a former Product Management at Shazam and Chief Product Officer & Co-Founder at Spylight. Ms. Koh received a bachelor of arts in Sociology and Computer Science at Yale University.
Follow April Koh:
About Spring Health: Spring Health provides employers with a comprehensive and effective solution for employee mental well-being.
Founder & CEO of Viome
Naveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is the founder of several successful companies including Moon Express, BlueDot, Viome, Intelius, TalentWise and InfoSpace. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon. It’s developing technologies to harvest planetary resources on the moon for the benefit of humanity. BlueDot is focused on bringing most promising technological innovations from the national labs, NASA and elite universities and supercharging them with great entrepreneurs to create successful enterprises that tackle humanity’s grand challenges. Viome is focused on discovering predictive biomarkers to eradicate all diseases. Our initial goal is to provide personalized diet & nutrition based on deep analysis of microbiome, metabolome and meta genomics. Naveen Jain a trustee of the board and vision circle member at the X PRIZE Foundation where he is focused on finding entrepreneurial solutions to address the global challenges in health, education, women empowerment, agriculture, and energy. Naveen Jain is on the board of Singularity University, an interdisciplinary university with the mission to educate and inspire leaders to address humanity’s grand challenges through innovative technologies. Naveen Jain has been awarded many honors for his entrepreneurial successes and leadership skills including “Ernst & Young Entrepreneur of the Year”, “Albert Einstein Technology Medal” for pioneers in technology, “Humanitarian Innovation Award” at the United Nations, “Distinguished Global Thinker Award” by IILM, “Most inspiring Entrepreneur” by Andaaz TV, “Most admired Serial Entrepreneur” by Silicon India, “Top 20 Entrepreneurs” and “Lifetime Achievement Award” for the leadership in the technology industry and support of other entrepreneurs by Red Herring.
Follow Naveen Jain:
About Bellevue LifeSpring, BlueDot, Moon Express, TalentWise, Viome, World Innovation Inc: Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.
Saeju Jeong
CEO & Co-Founder of Noom
A serial entrepreneur from a young age, Saeju has always an intense desire to help people. He sits on South Korea’s Ministry of Science & Technology’s steering committee and the board of Chonnam Hospital, South Korea’s largest private hospital.
Follow Saeju Jeong:
About Noom: Noom is a psychology-based digital health platform used to provide intelligent nutrition and exercise coaching.
Jessica Richman
Co Founder & CEO of uBiome
Jessica Richman is the co-founder and CEO of uBiome, a startup that uses big data and citizen science to understand the human microbiome. Jessica started and sold her first company after high school. Returning to formal education, she attended Stanford University, where she earned degrees in Economics and Science, Technology & Society (interdisciplinary engineering, emphasis in computer science). Along the way, she worked for Google, McKinsey, Lehman Brothers, the Grameen Bank, and top-tier Silicon Valley venture firms as well as other entrepreneurial projects and adventures. Her work has been published in The New York Times and other national publications. Jessica arrived at Oxford University as a Clarendon Scholar and completed an MSc at the Oxford Internet Institute. Currently a Green Templeton DPhil Scholar, her academic interests include network analytics, innovation, and collective intelligence. Her work has been featured in Wired, MIT Technology Review, Scientific American, NPR, FoxNews, ABC News, and dozens of other media outlets. She has spoken at TEDMED, TEDxBrussels, Partnering for Cures, the American Society for Microbiology, HealthFoo, SciFoo, Oxford University, the University of California San Francisco, and many other conferences and venues.
Follow Jessica Richman:
About uBiome: uBiome is a provider of public access to DNA sequencing technology to understand the microbiome.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
David Ko
Co-founder and CEO of Ripple Health Group
David Ko is the Co-founder and CEO of Ripple Health Group (RHG), an early stage healthtech startup focused on helping people experience healthier lives by connecting them to the care, support, and community they need. Prior to RHG, David was the President, COO and Board Member of Rally Health, a digital health company that develops online and mobile solutions that make it easy for consumers to take charge of their health and health care. Rally’s solutions are currently available to nearly 55 million people through health plans, care providers, and more than 200,000 employers. Prior to joining Rally, David oversaw all strategy, planning and operations as COO at Zynga, which he helped take public in December 2011. At the time of its IPO, Zynga was the largest social gaming company in the world with over 100 million daily active users. Prior to his work at Zynga, he spent 10 years at Yahoo! in various senior executive roles, including SVP of Yahoo!’s audience, mobile, and local businesses. David serves on the board of overseers at his alma mater New York University Stern School of Business where in 2016 he established the NYU Stern Venture Fellows program for aspiring entrepreneurs. He also works as an advisor and investor to a number of companies in Silicon Valley including Calm, the number one app for Sleep, Meditation and Relaxation.
Follow David Ko:
About Audax Health Solutions, Calm, Ripple Health Group: Ripple Health Group is a platform for the world’s most trusted healthcare solutions.
Felix Bustos III
Co-Founder & CEO of ZB Technologies, Inc.
Felix is passionate about using emerging technologies and inspiring others to prevent cancer. His purpose in life is to help end cancer. After losing his mother, sister, niece, and two cousins to cancer, he committed to the mission of winning the fight against cancer through artificial intelligence, emerging technologies, precision nutrition, and preventive healthcare. During the Fall of 2019, Felix, together with a team of software developers, engineers, data scientists, and physicians, soft-launched HelenHealth.co, a digital health platform that connects people with the best oncology healthcare resources. While in graduate school he conducted research on artificial intelligence and developed a machine learning model for digital health platforms. The venture was developed at the Harvard Innovation Labs’ Venture Incubation Program and accelerated through Harvard Medical School’s Healthcare Innovation & Commercialization Fall 2020 cohort, as the team relentlessly synergizes new approaches to solving the cancer problem. The venture’s long-term vision is, to connect a global Digital Health Ecosystem with the best resources available for everyone to live a disease-free life. Prior to co-founding a health technology company, Felix spent more than a decade in leadership and senior-level positions at Fortune 500 and high technology startup companies. At Virgin Galactic (NYSE: SPCE), he was part of the early R&D team that conceptualized an air-launched rocket, LauncherOne, prior to the project spinning off to Virgin Orbit (NASDAQ: VORB). He was also an early-stage team member at The Spaceship Company, which worked on SpaceShipTwo and a hybrid rocket engine. While at BAE Systems, he was part of an air-launch space transportation system team, now Paul Allen’s Stratolaunch. He started his R&D career at Lockheed Martin Skunk Works (NYSE: LMT). Felix was also on active duty in the U.S. Air Force and serves in the U.S. Coast Guard Reserve, as a joint staff officer, and is currently a reserve officer at the Defense Innovation Unit in Mountain View, California, providing technical/scientific expertise within the Space and Human Systems portfolios, and is the reserve lead for Artificial Intelligence. Awardee in The Top 100 Harvard Alumni in Technology of 2021.
Follow Felix Bustos III:
About ZB Technologies, Inc.: We’re a Health Technology company passionate about ending cancer by providing everyone with the best healthcare ecosystem.
Zachariah Reitano
Co-Founder and CEO of Ro
Zachariah is the CEO and cofounder of Ro. Founded in 2017, Ro is a healthcare technology company with a mission to provide personalized healthcare to everyone on the planet. Ro has three end-to-end verticals: Roman (men’s health), Rory (women’s health), and Zero (fighting addiction). As CEO and cofounder, Zachariah leads all medical and regulatory operations and oversees all verticals. Zachariah was named Inc. Magazine’s 30 Under 30, Business Insider’s 30 Under 40 in Healthcare, and a finalist in EY’s Entrepreneur of the Year. Ro was named #2 in Wellness in Fast Company’s World’s Most Innovative Companies 2019.
Follow Zachariah Reitano:
About Ro, Roman: Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Eric Marcotulli
Chief Executive Officer of Elysium
Follow Eric Marcotulli:
About Elysium: Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
Alessandra Lezama
CEO of TOOTRiS
Alessandra Lezama is an entrepreneur and PE backed CEO, advocate for women pursuing careers in tech and other STEM fields, angel investor to San Diego-based early-stage companies and Founder and CEO of TOOTRiS, an on-demand Child Care technology platform that is reinventing how parents access and pay for affordable, high-quality Child Care. Passionate about technology, Alessandra has enjoyed an illustrious career of taking underperforming tech companies and turning them into scalable, high-performance powerhouses. Prior to founding TOOTRiS, Alessandra was the CEO for multiple technology companies, including AbacusNext, a San Diego-based company she stepped into with 29 employees and, in less than four years, transformed into a disruptive global technology organization with more than 500 employees across San Diego, Canada and the United Kingdom. Companies under Alessandra’s leadership have been recognized in Forbes and Inc., and in 2016 and 2017 she was named “Women Who Mean Business,” in 2018 as “Most Admired CEO of the Year” and in 2019 as “Most Influential” by the San Diego Business Journal. Alessandra is a member of the San Diego Regional Chamber of Commerce, serving on its board and management council. She serves on the board of Doors of Change, a non-profit that is helping to break the cycle and save the lives of runaway, homeless, and trafficked young people. She is a member of the California Preschool Business Advisory Council, supporting efforts to produce viable policy for high quality early education that gives a competitive edge for California’s businesses, both immediately and the future.
Follow Alessandra Lezama:
About TOOTRiS: TOOTRiS is a technology platform that allows parents affordable access to high-quality Child Care, anytime, anywhere.
Stephanie Tilenius
CEO, Founder of Vida Health
Stephanie is CEO & Founder of Vida Health.
Follow Stephanie Tilenius:
About Nextdoor, Vida Health: Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Anil Sethi
Founder & CEO of Ciitizen
Anil Sethi lost his little sister Tania on 9/11/17 to metastatic breast cancer. From “oh my God don’t let it be cancer” to Tania’s last wishes, he’s experienced the caregiver journey, firsthand. In honor of Tania, Anil recently founded his sixth consumer-health venture, Ciitizen. To help kill cancer, in our lifetime. In 2016 Apple acquired Sethi’s consumer health startup Gliimpse which helped patients manage their health records. He also founded Sequoia, shepherding it through three venture rounds and in 2000 completing an IPO (Nasdaq: SQSW) before Sequoia’s sale to Citrix in 2001 for its patient-portal business. In 2004, WebMD (Nasdaq: WBMD) acquired Sethi’s first startup, Dakota Imaging, for its healthcare claims processing business.
Follow Anil Sethi:
About Ciitizen: Ciitizen’s mission is empower patients with complete control of their health data.
Patrick Nagle
Founder and CEO of Rehab.com
Patrick Nagle is a leading expert on digital strategy and has been featured in major media including Time Magazine, Wall Street Journal, CBS News, Forbes, New York Times, and Fox News. Nagle was the first investor and CEO of RateMyProfessors.com, an review site for college students. RateMyProfessors.com was acquired by Viacom’s MTV Networks on January 17, 2007 for an undisclosed sum. In addition to RateMyProfessors.com, Nagle purchased RateMyTeachers.com from California-based Mister Message, LLC on April 2, 2008. RateMyTeachers.com was acquired by an undisclosed private equity group in 2018. At the time of its sale, RateMyTeachers.com reached 20,000,000 annual users. Patrick Nagle is currently the Founder and CEO of Rehab.com, LLC.
Follow Patrick Nagle:
About Rehab.com: Rehab.com connects patients with providers who care.
Ed Park
Co-Founder & CEO of Devoted Health
Follow Ed Park:
About Devoted Health: Devoted Health is a healthcare company serving seniors and giving them a health care plan with personal guides and world-class technology.
Dustin DeVan
CEO of AWAIR
Dustin D. is a Board Member / Investor and CEO for Awair since Mar-2021.
Follow Dustin DeVan:
About AWAIR: Awair’s mission is to empower people worldwide to breathe safely through cutting-edge indoor air quaity monitoring.
Aaron Kaufman
CEO & Chairman of OpenMed
Follow Aaron Kaufman:
About : OpenMed is a digital innovator in closing care gaps, enabling access to care, and supporting real-time collaboration.
Alyson Watson
Founder & CEO of Modern Health
Alyson Friedensohn is a founder and CEO at Modern Health.
Follow Alyson Watson:
About Modern Health: Modern Health is a mental well-being platform for innovative companies offering therapy, coaching, and self-guided courses all in one app.
Raja Dhir
Co-Founder and Co-CEO of Seed Health
Raja Dhir is a life sciences entrepreneur and Co-Founder of Seed Health, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy. Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms. Raja has negotiated multiple joint-ventures, strategic partnerships, technology transfer and licensing agreements with publicly traded companies (NYSE, LSE) and academic institutions (Harvard Medical School, UCLA). To date, entities he has co-founded own the rights to 15+ patents and research emerging from $25MM+ of non-dilutive funding over 10+ years from the Bill and Melinda Gates Foundation and National Institute of Health (NIH). Raja serves on the Editorial Board for the scientific journal, Microbiome. He is a member of the Microbiome Think Tank at Mass. General Hospital (MGH) and sits on the Advisory Committee for the International Scientific Association of Probiotics and Prebiotics (ISAPP). Raja is also a Director and Co-Chair of the Scientific Advisory Board for Micropia, a $20MM microbial ecology / education platform and the world’s first museum dedicated to microbes.
Follow Raja Dhir:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Ara Katz
Co-Founder and Co-CEO of Seed Health
Ara Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health. She has worked at the intersection of technology, consumer, design, and media is now working to steward a new standard in probiotics and how science is communicated to change how we discern evidence from evangelism to make the most informed choices for our bodies, our health, and our world. Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LMVH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16. Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America”, listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech”, and Create + Cultivate’s 100 List for STEM.
Follow Ara Katz:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Thomas Joyce
President & CEO of Danaher
Thomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio. Thomas has more than 20 years of Danaher leadership experience. Prior to his appointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment. In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy. Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006. Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes. Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.
Follow Thomas Joyce:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Stephen Hadley
Chief Executive Officer of Pathway Partners Vet Holding
Prior to joining Pathway as Chief Executive Officer in 2017, Dr. Stephen Hadley served as Chief Operating Officer for BluePearl and Chief Strategy Officer for MedVet. He is the founder of TenTalents Capital, LLC, founding Director of VCA Specialty Animal Hospitals, and served as Group Vice President with VCA for 12 years. Dr. Hadley also founded the Aquarium of the Pacific in Long Beach. He earned his BS, MS and DVM degrees from the University of Illinois in Champaign-Urbana, IL followed by a surgical internship and residency in Los Angeles. He later earned an MBA from The Wharton School at the University of Pennsylvania.
Follow Stephen Hadley:
About Pathway Partners Vet Holding: Pathway Vet Alliance is a veterinary hospital owner and operator.
Hari Sundram
Chief Executive Officer of Radion Health
Follow Hari Sundram:
About QMedic, Radion Health: Radion Health offers turnkey stop-loss solutions to brokers, consultants, and TPAs.
Brenton Saunders
Chairman, President and Chief Executive Officer of Allergan
Brent Saunders is Chief Executive Officer and President of Allergan plc (formerly Actavis plc). Brenton previously served as Chief Executive Officer and President of Forest Laboratories and had served as a Member of the Board of Directors at Forest since 2011. Brenton has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, Brenton was Chief Executive Officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Brenton also held a number of leadership positions at Schering-Plough, including the position of president of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Brenton was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, Brenton was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brenton began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Brenton serves on the Board of Trustees of the University of Pittsburgh. Brenton is also the former Chairman of the New York chapter of the American Heart Association. Brenton is a Member of the Business Council and PhRMA. Brenton earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his Bachelor’s degree from the University of Pittsburgh.
Follow Brenton Saunders:
About Allergan, Cisco: Allergan is a global pharmaceutical company.
Cheryl Cheng
Founder and CEO of Vive Collective
Cheryl Cheng joined BRV in 2008. She focuses on early stage consumer and mobile big data opportunities. Cheryl also runs BRV’s alumni entrepreneur and Fortune 500 programs to bring experience and resources to the current portfolio. Prior to BlueRun, Cheryl worked at Clorox and The Sharper Image launching new products and driving retail marketing with partners across Target, Walmart and grocery. Cheryl has a B.A. from Stanford University and an MBA from Kellogg School of Management where she was a Forte Scholar. She is a mentor at Stanford’s Bio-Design for Mobile Health course, a collaboration between Stanford’s School of Medicine and School of Engineering.
Follow Cheryl Cheng:
About Vive Collective: Vive Collective is involved in improving quality and access to care by developing, funding, and growing digital health companies.
Ric S Kolluri
Co-founder & CEO of Bitcare
Hyper focused on transforming healthcare through technology and innovation. Developing a unified personalized care model for connected health consumers and patients.
Follow Ric S Kolluri:
About Bitcare: Unified Personalized Healthcare for the connected health consumers & patients.
Charlie Bachtell
Founder and CEO of Cresco Labs
Charles Bachtell serves as Co-Founder and Chief Executive Officer at Cresco Labs, LLC. He served as an Executive Vice President and General Counsel at Guaranteed Rate, Inc. Charles Bachtell served as the head of the legal and loss mitigation departments at Guaranteed Rate. He managed matters concerning legal, regulatory/legislative compliance, credit risk, corporate governance, and acquisitions, among others. Additionally, he is a board member of the Guaranteed Rate Foundation, the company’s nonprofit (501 c3) arm. Charles Bachtell worked with Guaranteed Rate. He obtained his Bachelor of Science degree in business administration with an emphasis in finance from the University of Arizona from 1996 to 2000 and his Juris Doctor from DePaul University College of Law.
Follow Charlie Bachtell:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Abilash Krishna
Co-founder & CEO of CareStack
Abhi is a visionary entrepreneur who brings a decade of expertise building technology platforms in US healthcare. His business acumen, decision making, and analytical skills are shaping CareStack to be a force in the dental and retail healthcare space.
Follow Abilash Krishna:
About CareStack: CareStack is a practice management platform for dental groups to manage all of their software and daily operations through one platform.
David Kopp
Chief Executive Officer of Healthline Media
David leads the Healthline Media team. His 25 year career spans publishing, digital advertising, consumer services, and clientside marketing for both big brands (Disney and Yahoo!) as well as more entrepreneurial ventures. David believes that people need better tools, education, and support in order to achieve good health, and he’s confident that Healthline’s purpose-driven team will make the world stronger and healthier. He also talks a lot about sugar: if you want to live a long, healthy life, minimize your sugar intake.
Follow David Kopp:
About Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Sam Santhosh
Founder Chairman & Global CEO of MedGenome
Sam Santhosh is the Founder and CEO of MedGenome. He has been an entrepreneur, with over 20 years of experience in the software industry. Currently, he is at the helm of affairs as CEO and promoter of MedGenome Labs Pvt Ltd. Sam sits on the board of a number of companies, both in the US and India. In this role he advises, guides and mentors companies to help them grow and realize their true potential. Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 – Feb 2012. He founded Calsoft in 1992 and under Sam’s vision, Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft Public and the company is listed the in Indian Stock Exchanges. Sam oversaw the growth of Calsoft in all key areas – Finance, Strategy, Customer Acquisition, and inorganic growth through eight acquisitions including companies in the U.S, UK, Japan, and India. He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India’s premier institute, IIM Calcutta.
Follow Sam Santhosh:
About Agrigenome, MedGenome: MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
David Vivero
Co-Founder & CEO of Amino
David Vivero is co-founder and CEO at Amino, guiding the vision and direction of the company and its personalized, consumer-centric, and data-driven approach to health care. Previously, David was VP of Rentals at Zillow, responsible for the world’s largest online rental marketplace. He arrived at Zillow after the company acquired RentJuice, which he cofounded in 2008. David is also a General Partner at Red Swan Ventures, a seed investment fund that has supported Warby Parker, Birchbox, AltSchool, and dozens of other high growth companies. A Forbes “30 under 30” entrepreneur, David has a BA and MBA from Harvard University.
Follow David Vivero:
About Amino, Red Swan Ventures: Amino is an all-in-one healthcare financial wellness platform for employees.
Andrew Adams
CEO of Headway
Follow Andrew Adams:
About Headway: Headway is a mental healthcare system provider that helps patients connect with therapists and submit insurance claims online.
David Lortscher
Co-Founder & CEO of Curology
David Lortscher, MD, is a licensed physician and a board-certified dermatologist. While working at a small but very busy dermatology practice in New Mexico, Dr. Lortscher saw that there were economic, geographical, and psychological barriers to seeing a dermatologist. He also noticed how changes in a person’s skin can have a tremendous impact on his or her life both socially and emotionally – and that’s when he had the idea to create Curology. Since its launch in 2014, Curology has been dedicated to removing barriers and helping people feel good about their skin. In addition to seeing patients at Curology, Dr. Lortscher serves as a remote dermatology consultant for the American Academy of Dermatology’s AccessDerm program.
Follow David Lortscher:
About Curology: Curology is a cosmetic company that provides actual prescription skincare customized for their skin and delivered to their door.
Brent Clements
Founder & CEO of Addiction Campuses of America
Brent is an accomplished entrepreneur, executive, and healthcare visionary. With over 20 years experience in senior leadership roles for multiple organizations in the healthcare and technology industries, Brent has a clear plan for what is required to build a successful company. Brent’s passion for helping those families in need inspired the founding of Addiction Campuses. Throughout his professional career Brent has developed expertise in creating strategy for the future, maximizing organizational efficiency, and building relationships with care givers, employees and community partners who drive change. Ultimately Brent believes “If they change the core belief system, the mindset changes and good behavior follows”. That is what Addiction Campuses is all about. He was recognized as one of Nashville Business Journal’s 40 Under 40 in 2011 and Healthcare Heroes nominee in 2010. Brent is married to his wife, Vicki, and they have two sons.
Follow Brent Clements:
About Addiction Campuses of America: Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.
Sylvana Quader Sinha
Founder, Managing Director and CEO of Praava Health
Sylvana Q. Sinha is founder and CEO of Praava Health, a leading healthcare company focused on improving health outcomes and patient journeys in emerging markets, where 85% of the world lives but whose current systems typically prioritize profits over patients.
Since launching in 2018, Praava has become Bangladesh’s fastest-growing consumer healthcare brand, and was designated a 2021 World Economic Forum Technology Pioneer and 2020 Fast Company World Changing Idea and Developing World Technology. Praava has served more than 300,000 patients and is tripling growth each year. Throughout the COVID-19 pandemic, Praava quadrupled its patient base while maintaining an NPS rating of 91.3—significantly exceeding even the highest scores of Fortune 500 companies.
Sylvana also has decades of experience leading teams in international law, business, development, and government relations at major international law firms, management consulting firms, the World Bank, and think tanks in the Middle East and S. Asia. In addition to serving as an advisor to then-Senator Obama, she has independently advised private and sovereign clients on investments, projects, and disputes in the Middle East, Africa, and S. Asia.
Sylvana is a Life Member of the Council on Foreign Relations, a member of the World Economic Forum’s UHC2030 Private Sector Constituency, and served on Mount Sinai’s Arnold Institute of Global Health Task Force for Global Advantage. She is a graduate of Columbia Law School, Harvard’s Kennedy School, and Wellesley College and was a Visiting Scholar at the University of Oxford.
Follow Sylvana Quader Sinha:
About Praava Health: Praava Health is a patient-driven company disrupting the healthcare standard for Bangladesh’s 170 million citizens.
Yingshuang Chai
Co-Founder & CEO of NuProbe
Yingshuang Chai is a Co-Founder, CEO, and Chairman of the Board of Directors at NuProbe.
Follow Yingshuang Chai:
About NuProbe: An early stage molecular diagnostics company.
Christopher Morris
Founder & CEO of Daybreak Health
Christopher is an Internal Medicine and HIV specialist at NYU Langone Medical Center focused on digital health innovations as means to transform health care quality and access. He is most interested in using emerging telehealth technologies to transform the primary care experience.
Follow Christopher Morris:
About Daybreak Health, NYU Langone Health, NYU Langone Medical Center: Daybreak Health is a digital health platform that facilitates mobile care solutions.
William F McKeon
CEO of Texas Medical Center
Mr. William F. McKeon serves as the Chief Executive Officer of Texas Medical Center in Houston, TX. Prior to joining the TMC leadership, he was the CEO of Cellnovo Limited. Mr. McKeon served as President of MicroPort Medical (Shanghai) Co. Ltd. since August 2006. He joined MicroPort Medical Co. Ltd. in 1997, where he was responsible for its marketing, eCommerce and eHealth initiatives. His professional career began at Du Pont where he held several marketing and business development roles in the United States and Europe. Prior to joining MicroPort Medical Co.
Follow William F McKeon:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Robert C Robbins
President and CEO of Texas Medical Center
Robert C. Robbins became President and Chief Executive Officer of Texas Medical Center on November 5, 2012. Prior to that, he was professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, where he served as a member of the faculty since 1993. He served as director of the Stanford Cardiovascular Institute, of the Heart- Lung and Lung Transplantation Programs, and of the Cardiothoracic Transplantation Laboratory. Dr. Robbins is an internationally recognized cardiac surgeon who has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices. He served as the guest editor of the Circulation Surgical Supplement from 2002 to 2005, president of the International Society of Heart and Lung Transplantation in 2006, president of the Bay Area Society of Thoracic Surgeons in 2006, chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council from 2007 to 2009, councilor-at-large for the Western Thoracic Surgical Association from 2007 to 2009, and on the President’s Cabinet at California Polytechnic State University from 2006 to 2012. In California, he served on the Board of Directors for two publically traded companies, Cohesion Technologies from 2000 to 2003 and Cardica, Inc. from 2000 to2009, and as a director for several other privately held Bay Area biotechnology companies. In 2009, he was elected to the American Heart Association Western States Affiliate Board of Directors and currently serves as president of the organization. He was elected to the Board of Trustees of Millsaps College in Mississippi in 2010. Dr. Robbins has lectured widely and published more than 292 peer reviewed articles. He earned his bachelor’s degree in chemistry from Millsaps College in 1979 and a medical degree from the University of Mississippi in 1983. He completed his general surgical training at the University of Mississippi in 1989 and his cardiothoracic training at Stanford University in 1992. Dr. Robbins completed post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital. An ex-officio of the Houston Livestock Show & Rodeo, Dr. Robbins currently sits on the Advisory Board of the Ronald McDonald House in Houston and on the Board of Directors for Texas Medical Center, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, the Houston Academy of Medicine Texas Medical Center Library, the Houston Technology Center, and the Friends of Houston Academy of Medicine Texas Medical Center Library.
Follow Robert C Robbins:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Ken Cahill
CEO of SilverCloud Health
Ken Cahill is the CEO and co-founder of SilverCloud Health with offices in Boston, Dublin, and London. SilverCloud is the world’s leading digital mental health platform. It enables the delivery of clinically validated digital therapeutic care programs that are proven to significantly improve clinical outcomes, increase access & scale while reducing costs of care delivery. SilverCloud’s multi-award winning platform has spun out from 16 years of clinical research with leading academic institutions, including MIT Media Lab. Today, SilverCloud provides customized solutions for over 240 organizations globally to meet the mental health & chronic care needs of their end users/patients. The platform has been profoundly validated through the use of full randomized control trials as well as real-world data from over 250,000 active SilverCloud end users. Prior to founding SilverCloud Health, Ken held senior positions in several multinationals including, Dell, HP, and Gateway. Ken recently received the 2018 MedTech Boston 40 under 40 award.
Follow Ken Cahill:
About SilverCloud Health: SilverCloud Health provides immediate access to evidence-based and supported digital therapies.
Katherine Wells
Founder, CEO of Serenity Engage
Katherine Wells is the Founder and CEO at Serenity Engage.
Follow Katherine Wells:
About CodeBaby, Mavericks, Serenity Engage: Serenity Engage is a HIPAA-compliant messaging app platform for senior care.
Ken Tarkoff
Chief Executive Officer of Syapse
Ken Tarkoff is a health technology veteran with deep experience in facilitating physician, health system, and health plan relationships. Before joining Syapse, Ken most recently served as the Senior Vice President and General Manager at RelayHealth Intelligence, a data and analytics business owned by McKesson, and as Chief Operating Officer of RelayHealth before the company was acquired. Previously, Ken held leadership positions at Xign Corporation, Questium, and Vivra Specialty Partners. Ken holds an MBA from Northwestern’s Kellogg School of Management and a BA from Amherst College. Ken enjoys spending time with his wife and two high-school-age kids, one of whom is currently making her college decisions. He also enjoys watching his son play water polo or going out for a few rounds of golf when he has the time.
Follow Ken Tarkoff:
About Syapse: Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care
Merritt Dake
CEO of Greyfinch
Merritt Dake is the Chief Executive Officer at Rock Dental Brands.
Follow Merritt Dake:
About Greyfinch, Rock Dental Brands: Greyfinch is an orthodontic practice management software.
Derek Lampert
Chief Executive Officer of Drive Medical
Follow Derek Lampert:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Andrew Hayek
Chief Executive Officer of UnitedHealth Group
Andrew Hayek has served as our Chief Executive Officer since 2008. Prior to joining SCA, Andrew served as the President of a division of DaVita Healthcare Partners (a renal dialysis and medical group provider), as President and Chief Operating Officer of Alliance Healthcare Services (a diagnostic imaging and radiation therapy provider), and in roles at Kohlberg Kravis Roberts & Co. (a global investment firm) and the Boston Consulting Group (a global management consulting firm). Andrew is a Henry Crown Fellow at the Aspen Institute and serves as Chairman of SCA Medical Missions (a surgical mission program). Andrew also serves as Chief Executive Officer of OptumHealth, one of three segments of Optum and the one that includes SCA. Andrew earned a Bachelor of Arts summa cum laude from Yale University.
Follow Andrew Hayek:
About Firsthand, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Robert Boisjoli
CEO & Board Member of AKESOgen
Robert Boisjoli is Founder & Chief Executive Officer at AKESOgen.
Follow Robert Boisjoli:
About AKESOgen, Atwater Financial Group: AKESOgen is a biomarker, genomics, and pharmacogenomics contract research organization.
Adeel Malik
Chief Executive Officer of Clearstep
While studying finance and neurobiology in undergrad, Adeel spent his time doing neuro-immunology research at the Johns Hopkins Hospital, contributing to several academic publications. After undergrad, Adeel was a strategy & analytics consultant with Accenture for several years where he worked with some of the largest institutions in healthcare across pharma, health tech, health systems, and retail clinics. Adeel’s skillets in healthcare analytics, operations, sales, and his breadth of experience across the healthcare ecosystem enable him to lead Lytic through the complexities of healthcare innovation.
Follow Adeel Malik:
About Clearstep: Clearstep is a platform for health systems to provide a complete and digital front door experience.
Marc D. Grodman
CEO of Bio-Reference Laboratories
Follow Marc D. Grodman:
About Bio-Reference Laboratories: BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing .
Joe Kahn
CEO of Karuna Health
Joe Kahn is a CEO and co-founder at Karuna Health.
Follow Joe Kahn:
About Karuna Health: Karuna connects patients with healthcare guides through streamlined communication and automation.
Tom Nix
CEO of Ria Health
Follow Tom Nix:
About Ria Health: Ria Health’s evidence-based telehealth alcohol treatment program helps people drink less and live better.
Jim Riley
Co – Founder & CEO of iCare
Jim Riley is the co-founder and CEO of iCare and has over 15 years of leadership experience in the Software as a Service (SaaS) industry. Mr. Riley had a single mission in mind when founding iCare in 2011; to create an on-demand health information management service to replace traditional enterprise software technology in the healthcare sector. Prior to founding iCare, Mr. Riley founded Learn.com, a cloud-based Human Capital Management provider where he acted as Chairman & CEO until the sale of the company. The innovative product set pioneered at Learn.com, is now part of Oracle Corporation. Mr. Riley led the company to the top of the industry in terms of customer success, analyst acclaim and product innovation. Mr. Riley received a B.S. in Systems Engineering from the University of Florida and served as a fighter pilot in the U.S. military.
Follow Jim Riley:
About iCare: iCare provides cloud-based EHR solutions to healthcare facilities.
Torri Shack
CEO / Co-Founder of Twella
Energetic and innovative Business Development Executive with more than 10 + years of experience in building and managing highly motivated sales and delivery teams. Flair for developing and growing market penetration through strategic partnerships, creative marketing and sales campaigns. Track record of building substantial sales and marketing teams and systems. PROFESSIONAL SUMMARY • Strong leadership skills with a proven history of building motivated and focused teams by investing in people through listening, coaching, training and mentoring. • 15 years’ experience in selling across a variety of platforms including outbound phone sales, cold calling, qualifying and converting leads, presentations, networking and managing a geographically distributed sales force. • Broad sales and business development experience across various industries including: property, mortgage, real estate, wellness, and technology. • Experienced in designing and implementing targeted focused sales and marketing campaigns with a track record of rapidly growing and maintaining market share. • Well-developed analytical and problem-solving skills. • Broad social media and technology experience with an innate understanding of what will work best on which platform. • Managed and exceeded KPI’s across various and diverse industries. • Strong financial management, budgeting and forecasting skills. • Highly organized with great time managements skills with the ability to focus on detail without losing sight of the bigger picture.
Follow Torri Shack:
About Tangible Movement, Twella: A mindful approach to mental wellness
Bridget Osetinsky
Founder & CEO of Hyperfine
Bridget is the Founder and Chief Executive Officer of Hyperfine. She earned her Juris Doctor from Temple University James E. Beasley School of Law in 2011 and her Bachelor of Science in Physics from the University of Notre Dame in 2007.
Follow Bridget Osetinsky:
About Hyperfine: Advanced Analytics For Precision Medicine
Jiang Li
CEO of VivaLnk
Jiang has both passion and extensive experience in bringing innovative technology and products into the marketplace. He has held various senior management positions in both large high tech organizations and startup companies. Prior to joining VivaLnk, he was responsible for new product and technology development as the VP of engineering in Kovio and Thinfilm Electronics, leading printed electronics companies. Prior to that, he worked at AMD and the joint venture between AMD/Fujitsu, Spansion. As the VP of product engineering in Spansion, Jiang managed the major new product launches in Spansion. Jiang holds a Ph.D. degree from the University of Wisconsin-Madison, and a bachelor’s degree from Zhejiang University in China.
Follow Jiang Li:
About VivaLnk: VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.
Mike McSherry
CEO & Founder of Xealth
CEO at Xealth.
Follow Mike McSherry:
About Xealth: Xealth is a platform for digital health, enabling clinicians to prescribe and monitor digital tools from within the EHR workflow.
David Warnock
CEO & Partner of Camden Partners
David is a Senior Partner of Camden Partners and co-founded the firm in 1995. He has over 25 years of investment experience and focuses on investments in the business and education sectors. He serves as Chairman of New Horizons Worldwide, Inc. and Calvert Education Services, LLC. In addition, he is a director of Primo Water Corporation, Questar Assessment, Inc., Ranir, LLC, Santa Rosa Consulting, Triumph Higher Education Group and Network for Good. He formerly served on the board of American Public Education, Inc., Nobel Learning Communities, Inc. Towne Park, Ltd., and National American University, all of which were Camden Partners portfolio companies. David was employed by T. Rowe Price Associates from 1983-1995. He served as President of T. Rowe Price Strategic Partners I & II as well as co-manager of the T. Rowe Price New Horizons Fund. David started his career at Welch and Forbes, Boston-based private trustees. David is also involved with numerous non-profit organizations. He is the Chairman of the Center For Urban Families and the Warnock Foundation, and was formerly the Chairman of the Greater Baltimore Committee. He is Founder and Trustee of the Green Street Academy in Baltimore City. He also serves as a trustee of the Baltimore Museum of Art and the Georgia O’Keeffe Museum. David earned a B.A. degree from the University of Delaware and a M.S. (in Finance) from the University of Wisconsin. David is also a Chartered Financial Analyst Charterholder.
Follow David Warnock:
About Camden Partners, Camden Partners, Center for Urban Families, Georgia O’keeffe Museum, Pinnacle Automotive Hospitality Services, Warnock Foundation: Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.
Jeff Wells
Chief Executive Officer & Co-Founder of Marathon Health
Follow Jeff Wells:
About Marathon Health: Marathon Health offers a proven solution for helping employers reduce the total cost of healthcare
Rachel E. Haurwitz
Co-founder, President & CEO of Caribou Biosciences
Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception. She has a research background in CRISPR-Cas biology, and is also a co-founder of Intellia Therapeutics. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.
Follow Rachel E. Haurwitz:
About Caribou Biosciences: Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Hugo Saavedra
Founder and Chief Executive Officer of Hugo & Debra Natural
Follow Hugo Saavedra:
About Hugo & Debra Natural: Hugo & Debra Natural is an all-natural personal body care line made from natural food-grade ingredients.
Mario Schlosser
CEO of Oscar Health
Mario Schlosser is the CEO and co-founder of Oscar, a health-insurance start-up that is using technology, design, and data to help humanize and simplify healthcare. Previously, he co-founded the largest social gaming company in Latin America, where he led the company’s analytics and game design practices. At Bridgewater Associates, Mario developed analytical trading models as a Senior Investment Associate. Prior to Bridgewater, he worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil. As a visiting scholar at Stanford University, Mario wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed an algorithm to securely compute trust in randomized networks. He holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.
Follow Mario Schlosser:
About Bridgewater Associates, Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Connie Wan
Founder and CEO of Seattle Gummy Company
Connie Wan Business, technology and IP executive with proven sucess in technology and product development and commercialization; intellectual property creation, portfolio strategies, management and commercialization; IP landscape and whitespace analysis; patentability search; patentability and freedom to operate analysis and opinions; IP due diligence; patent validity and infringement analyses; IP assets evaluation, acquisition, and licensing; technology transfer; IP strategy, patent portfolio development and trademark strategy for startups; inventors training, development, and management; patent preparation and prosecution in the fields of chemistry, pharmaceutics, therapeutic methods, biotechnology, medical devices, polymers, material sciences, and nanotechnology; design patent preparation and prosecution; client counseling and case management; trademark searches and availability opinions; trademark registrations, oppositions, and cancellations; and limited amount of copyright work.
Follow Connie Wan:
About Seattle Gummy Company: A specialty pharma company focusing on delivering drug ingredients (APIs) using innovative gummy (chewable gel) formulations.
Waleed Mohsen
Founder & CEO of mynurse.ai
Follow Waleed Mohsen:
About mynurse.ai: a digital health program to help seniors with chronic conditions live their best lives.
Agustin Fernandez III
CEO & Co-Founder of Rational Vaccines
Follow Agustin Fernandez III:
About Duende Media, Rational Vaccines: Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
David Cordani
President & CEO of Cigna
David Cordani is the President (since 2008) and Chief Executive Officer at Cigna since December 2009. David is also a Member of the Board of Directors at Cigna since 2013. David has led Cigna’s transformation from a traditional health insurer into a leading, global health service company, with a focus on helping people improve their health, well-being and sense of security. Since becoming President and Chief Executive Officer in 2009, Cordani has successfully galvanized Cigna’s more than 35,000 employees–in more than 30 countries–around a global product and service repositioning, guided by the company’s differentiating “Go Deep, Go Global, Go Individual” strategy. Previously, David was the Chief Operating Officer from June 2008 until December 2009, President of Cigna HealthCare from 2005 until 2008 and Senior Vice President of Customer Segments and Marketing for Cigna HealthCare from 2004 until 2005. David has been employed by Cigna since 1991. David is an accomplished triathlete, having competed in more than 125 triathlons. David earned a Bachelor’s degree from Texas A&M University and an MBA from the University of Hartford.
Follow David Cordani:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Justin Guilbert
Founder & Co-CEO of Bravo Sierra
Justin Guilbert is a co-founder and co-CEO at Bravo Sierra.
Follow Justin Guilbert:
About Bravo Sierra, GoodFish, Harmless Harvest, Intraloop: Bravo Sierra is the military-native performance wellness company.
Paul Johnson
CEO of Lemonaid Health
Paul is the co-founder and CEO of Lemonaid Health. He moved from the UK to the US in 2014. In the UK Paul’s entrepreneurial career started aged 17 where I was a runner up in a Daily Mail sponsored entrepreneur of the year competition and founded his first company ran from the garage of his family home. Later Paul founded and ran the UK’s largest online pet retailer and became Head of Online for the second largest drugstore chain. Paul continues to advise McKinsey & Company and others on e-commerce, innovation and business strategy. In the UK Paul was an advisor to the Government on Entrepreneurism and Enterprise.
Follow Paul Johnson:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
David E. Weekly
CEO of Medcorder
David is a nerd who likes people. David runs the product org for the datacenter software team at Google and previously helped launch internet.org at Facebook, helping to connect the species to the Internet. Before that, he started and ran Ohana (a service to help parents share videos of their kids with extended family) and PBwiki (the first private hosted wiki company), still used by millions of people a month. He was the Founding Director of Hacker Dojo, one of the world’s largest hackerspaces, located in Mountain View, and was the Founding Partner of Mexican.VC, Silicon Valley’s first seed fund for Mexican Internet startups and the best performing Mexican tech fund in history. David has been programming since he was five and graduated from Stanford with a degree in Computer Science as a President Scholar. He has worked in such widely varying technology environments as Harvard Physics Labs, MIT Lincoln Labs, Stanford Graphics Labs, atWeb (acquired by Netscape), myplay (acquired by Bertelsmann), Legato (acquired by EMC), and There.com (where he worked with Eric Ries, the inventor of The Lean Startup methodology). David has served as an advisor to dozens of technology companies, including Plaxo (acquired by Comcast), Attassa (acquired by YouSendIt), and Like.com (acquired by Google).
Follow David E. Weekly:
About Medcorder: Medcorder is a mobile app that helps families to coordinate and communicate about patient care.
Francis deSouza
CEO of Illumina
Francis A. deSouza, 50, has been President and Chief Executive Officer of Illumina, Inc., a biotechnology company, since 2016 and served as President of Illumina from 2013 to 2016. Prior to joining Illumina, Mr. deSouza was President, Products and Services, of Symantec Corporation from 2011 to 2013, and Mr. deSouza served as Symantec’s Senior Vice President, Enterprise Security Group, from 2009 to 2011. Prior to that time he founded or worked in a variety of other technology businesses. He has served as a Director of Illumina since 2014 and was a director of Citrix Systems, Inc. from 2014 to 2016. He was elected a Director of the Company in December 2017, effective February 1, 2018.
Follow Francis deSouza:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Jay Flatley
President & CEO of Illumina
Jay was appointed President and CEO of Illumina in 1999 and oversaw the company’s expansion into the whole genome sequencing area with the acquisition of Solexa in 2006, and more recently into diagnostics and consumer sequencing. Under his leadership, Illumina has been named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. He helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Currently, he is an Advisory Board member for UC San Diego’s Moores Cancer Center, and a member of the Board of Directors at Coherent, Denali, and Illumina, Inc. Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.
Follow Jay Flatley:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Allen Chen
CEO & Co-Founder of Fitbod
Allen is the Co-founder & CEO of Fitbod.
Follow Allen Chen:
About Fitbod: Fitbod allows users to maximize the use of indoor gym equipment and confidence to train effectively for strength.
Robert Alexander
Chief Executive Officer of Allakos
Robert Alexander has been involved in the formation and leadership of numerous biotechnology companies. Robert Alexander was CEO of ZS Pharma where he led the initial public offering and sale of ZS Pharma to AstraZeneca. Prior to ZS Pharma, Robert Alexander was a Director at Alta Partners, a venture capital firm, and was also Executive Chairman and interim CEO of SARcode Bioscience. During his time at Alta Partners, he led investments in SARcode Bioscience (acquired by Shire), Lumena Pharmaceuticals (acquired by Shire), ZS Pharma (acquired by AstraZeneca), and Allakos. Prior to Alta Partners, Robert was a Principal in MPM Capital’s BioEquities Fund. Robert Alexander joined MPM from Genentech, where he worked in the Business Development group. Robert Alexander is on the Board of Directors of Allena Pharmaceuticals. He holds a PhD from the University of North Carolina at Chapel Hill and a Bachelor Science in Zoology from Miami University of Ohio.
Follow Robert Alexander:
About Allakos: Allakos is a biotechnology company that develops antibody-based therapeutics to treat various allergies and diseases.
Daniel Petkevich
CEO and Founder of Virgil Insurance
Daniel Petkevich is the CEO and Founder of Virgil Insurance.
Follow Daniel Petkevich:
About Fair Square Medicare, Virgil Insurance: Virgil Insurance is an insurance firm that offers various kinds of plans and experiences for seniors to shop for health insurance online.
Noubar Afeyan
Founder & CEO of Flagship Pioneering
Noubar Afeyan is Founder, Senior Managing Partner and Chief Executive Officer at Flagship Ventures, a leading early stage venture capital firm. Noubar also leads the firm’s VentureLabs unit that invents and launches transformative startups. Noubar is a Senior Lecturer at MIT’s Sloan School of Management where he has taught courses on technology-entrepreneurship, innovation and leadership since 2000. Noubar lectures widely in the United States and internationally on diverse topics ranging from entrepreneurship, innovation and venture capital to biological engineering, drug discovery, medical technologies and renewable energy. During his 28-year career as inventor, entrepreneur, CEO and venture capitalist, Noubar has co-founded and helped build over 35 successful life science and technology startups. Noubar was Founder and Chief Executive Officer at PerSeptive Biosystems, a leader in the bio-instrumentation field that grew to over $100M in annual sales within six years from its first sales. After PerSeptive’s acquisition by Perkin Elmer/Applera Corporation in 1998, Noubar was Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics. Currently Noubar serves on a number of public and private company boards including CiBO Technologies, Epiva BioSciences, Evelo BioSciences, Joule Unlimited, Kaleido BioSciences, Moderna Therapeutics, Pronutria Biosciences and Seres Therapeutics. Previously, Noubar was a Member of the founding team, Director and Investor in several highly successful ventures including Chemgenics Pharmaceuticals (acquired by Millennium Pharmaceuticals), Color Kinetics (acquired by Philips), Adnexus Therapeutics (acquired by Bristol-Myers Squibb) and Affinnova (acquired by AC Nielsen). Noubar received a Technology Pioneer 2012 award from the World Economic Forum in recognition of the breakthrough solar fuel technology being developed at Joule Unlimited. Noubar has served as Chairman of the Global Agenda Council on Chemicals, Advanced Materials and Biotechnology of the World Economic Forum as well as being a member of the Meta-Council on Emerging Technologies. Noubar is a Member of the Board of Overseers of the Boston Symphony Orchestra. In addition, he serves on the board of AmeriaBank and of UWC Dilijan International School, both of Armenia. Previously, Noubar was a Co-Founder and Member of the Board of Directors at National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the former Soviet Republic of Armenia. In 2008 Noubar received the Ellis Island Medal of Honor, an award granted to outstanding Americans who have distinguished themselves as United States citizens and who have enabled their ancestry groups to maintain their identities while becoming integral parts of American life. Noubar has authored numerous scientific publications and patents since earning his Ph.D. in Biochemical Engineering from MIT in 1987. Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.
Follow Noubar Afeyan:
About BIND Therapeutics, Cogen Therapeutics, Cygnal Therapeutics, Ensemble Therapeutics, Flagship Pioneering, Generate Biomedicines, Harvard Business School, Indigo, Joule Unlimited Technologies, Laronde, Massachusetts Institute of Technology, Moderna Therapeutics, Omega Therapeutics, Permeon Biologics, Ring Therapeutics, Rubius Therapeutics, Seres Therapeutics: Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Simba Gill
President & CEO of Evelo Biosciences
Simba Gill, PhD is an entrepreneur, investor and CEO who believes passionately that science and globalization will dramatically improve life in the 21st century. Dr. Gill is currently the CEO of Evelo, Sr. Partner at Flagship Ventures, and Executive Chair of Blackfynn. Dr. Gill founded or had lead roles in moksha8, Epirus, Maxygen, Verdia, Avidia, Codexis, Systemix and Valentis, four of these companies have been taken public and three were acquired through strategic trade sales. Exit valuations were between $400M – $6B. Dr. Gill has also led, built and launched several commercial businesses/products generating annual revenues of between $150M-$2B. Dr. Gill has founded and/or had lead roles in pioneering companies in the fields of antibodies, stem cells, directed molecular evolution, immunodiagnostics and the cancer microbiome. He has also been an investor, advisor, founder and CEO of several emerging market life science companies. Dr. Gill was a Partner at TPG, focused on investments in Life Sciences and Emerging Markets. Early in his career, Dr. Gill was co-head of Worldwide Marketing for Recormon. He also led corporate and market development and strategy from inception to commercialization of the Elecsys system, which became one of the world’s most widely used immunodiagnostic platforms. Dr. Gill served on the Board of Directors of the Tuberculosis Alliance, The Djerassi Resident Artists Program and the International Advisory Board of INSEAD. Dr. Gill was also the founder of Dispatches, an in-depth written and photojournalism periodical focused on key global issues. Dr. Gill has an MBA from INSEAD and carried out his PhD with focus on developing humanized antibodies to treat cancer. This work was done at King’s College, London in collaboration with the LMB at Cambridge and Celltech.
Follow Simba Gill:
About Epiva, Evelo Biosciences, moksha8 Pharmaceuticals, TPG Growth: Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.
Daniel Grau
President, Chief Executive Officer, and Director of Sojournix
Grau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.
Follow Daniel Grau:
About Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.
Alexandre Winter
CEO, co-founder of Norbert Health
Alex is both a computer vision geek and a repeat tech entrepreneur. Born and raised in France, a proud Brooklynite today, Alex is currently CEO and co-founder of a stealth mode health tech startup. Alex is also helping several VC funds as a venture partner – Scrum Ventures, Serena. Prior to this project, Alex was leading the Artificial Intelligence team at Arlo. Alex was the CEO and founder of Placemeter, a New-York based startup that quantifies human activity in cities using computer vision and video feeds. Placemeter raised 8m of venture capital and was sold to Netgear in December 2016. Prior to placemeter, Alex co-founded LTU Technologies, a venture backed startup, pioneer in large scale image search by content. As a CTO then CEO of the company, Alex helped bring LTU to profitability in three years. LTU was successfully acquired by a Japanese company listed on the Tokyo Stock Exchange. Prior to LTU, Alex was a researcher in Computer Vision at INRIA. He also worked at Airbus, building vision based missile guidance systems. Alex holds an MSc and a PhD in Image Recognition from Telecom ParisTech, holds 9 patents in the field. Alex also advises various startups in New York, and is a mentor of the Techstars NYC program. Prior to LTU, Alexandre was a researcher at INRIA in Paris, and a missile guidance engineer at Aerospatiale, now EADS. Alexandre holds a PhD in Computer Vision from Telecom Paristech and 10 patents in the field.
Follow Alexandre Winter:
About Norbert Health, Serena, Stealth mode health tech startup: Norbert Health develops a home medical pod that monitors the health of families using contactless sensors.
Pamela Sedmak
CEO of Aetna Medicaid of Aetna
Pamela Sedmak is the former senior Vice President and Chief Financial Officer for Blue Cross/ Blue Shield of Minnesota. She was responsible for all facets of financial operations at Blue Cross including business development, budgeting, forecasting, reporting and analysis. She has been honored as a Hall of Fame inductee by the Anderson School of Management at the University of New Mexico and has been very involved in professional and community associations including being a founding member of the Greater Cleveland Executive Women’s Leadership Forum. She received her degree in finance from the University of New Mexico and her M.B.A. in Executive Management from Case Western Reserve University in Ohio.
Follow Pamela Sedmak:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Mark Bertolini
Chairman and Chief Executive Officer of Aetna
Mark Bertolini is Chairman, Chief Executive Officer and President of Aetna, a Fortune 100 diversified health care benefits company with more than $47.2 billion in 2013 revenue. Aetna serves an estimated 44 million people with information and resources to help them make better informed decisions about their health care and has operations in North America, Asia, Europe and the Middle East. Bertolini assumed the role of CEO on November 29, 2010 and of Chairman on April 8, 2011. Bertolini joined Aetna in 2003 as head of Aetna’s Specialty Products. In July 2007, he was named president, responsible for all of Aetna’s businesses and operations across the company’s broad range of health care products and related services – including medical, pharmacy, dental, behavioral health, group life and disability plans, as well as medical management capabilities and health care management services for Medicaid plans. Prior to serving as Aetna’s president, Bertolini was executive vice president and head of Aetna’s regional businesses, which included the company’s individual, retiree, small group and middle market segments, as well as numerous product, network and service areas. Recognized as an accessible, forward-thinking and solutions-oriented leader, Bertolini is actively engaged in the national dialogue on health care reform, meeting regularly with state and federal policymakers to advocate for measures that increase access, lower costs and improve quality of health care. He is a strong advocate of market-based solutions, the expansion and use of health information technology, and the sustainability of the employer-based system. Firmly committed to diversity and inclusion, Bertolini also serves as the company’s executive sponsor for diversity, participates in several Aetna employee resource groups, and maintains a blog to communicate with employees. Among his civic activities, Bertolini serves on the Board of Directors of the U.S.-China Business Council, the Hole in the Wall Gang Camp, an organization founded by Paul Newman that serves children with cancer and other serious illnesses, and FIDELCO, an organization that breeds and trains guide dogs for the visually disabled. In 2009, he was elected the first straight ally board member of the National Gay and Lesbian Chamber of Commerce. Bertolini has been honored for his leadership by numerous universities and organizations, including the National Italian American Foundation, Outward Bound, the National Kidney Registry, Out & Equal Workplace Advocates, the Quinnipiac University Business School, and Wayne State University School of Business. Prior to joining Aetna, Bertolini held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he served as president and chief executive officer. Born and raised in Detroit, Bertolini held various jobs throughout high school and college, including assembly work at a Ford Motor Company plant and various caregiver roles in health care delivery.Bertolini is a spinal cord injury survivor and is partially disabled as the result of a severe skiing accident in 2004. In 2007, Bertolini donated a kidney to his son. His previous work and personal experiences with the health care system are foundational to his dedication to improving the patient experience and addressing the longstanding challenges facing the U.S. health care system. Bertolini holds an undergraduate degree in business administration/finance from Wayne State University and a MBA in finance from Cornell University.
Follow Mark Bertolini:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Nicholas Chang
CEO & Founder of The Pill Club
Follow Nicholas Chang:
About The Pill Club: The Pill Club provides online birth control prescription and at-home delivery services.
Seth Sternberg
Co-Founder & CEO of Honor
Seth Sternberg is the Co-Founder and CEO of Honor, a non-medical home care company with a mission to enable our parents to remain in their homes as they age. Prior to Honor, Seth was the Co-Founder and CEO of Meebo, which brought instant messaging to the web and reached close to half the internet population in the United States. Meebo was acquired by Google, where Seth became a Product Director working on the Google Identity Platform, and then within GoogleX. Seth started his career with IBM’s Corporate Development group after graduating from Yale.
Follow Seth Sternberg:
About Honor, Meebo: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Derek Streat
CEO of DexCare
Derek Streat is the Chief Executive Officer at DexCare.
Follow Derek Streat:
About DexCare, IROC (Improving Renal Outcomes Collaborative), Seattle Children’s, SpringRock Ventures: DexCare provides a Platform-as-a-Service offering to manage health system capacity and demand across all lines of care.
Paul Parmar
Founder & Group Chief Executive Officer of Constellation Healthcare Technologies
Parmar has provided consultancy services to a number of the world’s largest companies including a major healthcare company, to improve their operational platforms by reducing costs and driving efficiencies. Parmar has previously invested in healthcare businesses and technologies. In 2008 a group represented by Parmar bought a controlling interest in a medical billing company and subsequently sold the business to NextGen. In 2013 he founded Constellation Health to acquire Orion. Parmar built a private aviation business through both acquisition and organic growth which was sold to Delta Airlines in 2010.
Follow Paul Parmar:
About Constellation Healthcare Technologies, Pegasus Blue Star Fund, Vericlaim: Constellation Healthcare Technologies provides a holistic, integrated suite of practice management support services to hospitals.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Daniel Perez
Co-Founder, CEO of Hinge Health
With a long personal history of MSK injuries including several leg surgeries, Dan has long been passionate about improving outcomes for musculoskeletal disorders. Originally from Miami, Dan pursued a PhD in the medical sciences at the University of Oxford (currently paused), founding the Oxbridge Biotech Roundtable and OneStart, a large healthcare accelerator program. As CEO, Dan brings startup technology experience and healthcare expertise to Hinge Health.
Follow Daniel Perez:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Cary Gunn
CEO & Founder of Genalyte
Dr. Cary Gunn — who drives Genalyte’s strategic vision, direction, culture and success — has been blazing trails in the technology community for almost 30 years. Prior to leading Genalyte, Cary served as co-founder and chief technical officer of Luxtera, a developer of innovative optical solutions; his military career includes almost 10 years in the United States Air Force, where he was responsible for launching GPS satellites. Holding 81 (and counting) issued U.S. patents, Cary has been recognized in publications including the MIT Technology Review, which named him a Top Young Innovator in 2003. Five years later, Cary’s achievements in silicon photonics were awarded with the Optical Society of America Adolph Lomb Medal and the Berthold-Leibinger Foundation Innovation Prize. He received his bachelor’s degree in applied physics and organic chemistry from the United States Air Force Academy and his PhD in electrical engineering from the California Institute of Technology (Caltech). At Genalyte, Cary is proud to pioneer technology that has “a positive impact on life and human health.”
Follow Cary Gunn:
About Genalyte: Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Jeffrey Morin
Co-Founder and CEO of Liteboxer
Jeffrey Morin is the founder and CEO of Liteboxer.
Follow Jeffrey Morin:
About Liteboxer: Liteboxer is a provider of a digital fitness platform used to provide an engaging full-body boxing workout.
